z-logo
open-access-imgOpen Access
CRADA Final Report: ErbB2 Targeted Cancer Therapeutics
Author(s) -
Ruth Lupu
Publication year - 2002
Language(s) - Uncategorized
Resource type - Reports
DOI - 10.2172/1157017
Subject(s) - cancer research , erbb , breast cancer , neuregulin , receptor tyrosine kinase , medicine , activator (genetics) , prostate cancer , targeted therapy , ovarian cancer , prostate , oncogene , ovarian carcinomas , oncology , cancer , receptor , ovarian carcinoma , cell cycle

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom